Search research articles
Contact Us
Filters
Showing results (51-60 of 65) with videos related to
Page
of 7
Sort By:
Pharmacology, Biochemistry, and Behavior
|
February 1, 1990
Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity
P M Carvey, L C Kao, T J Zhang, et al.
Neuroscience Letters
|
November 22, 1988
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation
A McRae-Degueurce, H L Klawans, R D Penn, et al.
Experimental Neurology
|
March 1, 1993
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures
P M Carvey, L R Ptak, S T Nath, et al.
Neurology
|
March 4, 1998
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations
C G Goetz, E J Pappert, L M Blasucci, et al.
Brain Research
|
March 10, 2000
Striatal trophic activity is reduced in the aged rat brain
Z D Ling, T J Collier, C E Sortwell, et al.
Neurotoxicology and Teratology
|
March 1, 1994
Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity
D E Weese-Mayer, J M Silvestri, D Lin, et al.
Brain Research. Developmental Brain Research
|
December 28, 1999
Prenatal cocaine exposure reduces glial cell line-derived neurotrophic factor (GDNF) in the striatum and the carotid body of the rat: implications for DA neurodevelopment
J W Lipton, Z Ling, T Q Vu, et al.
Experimental Neurology
|
March 1, 1994
Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture
S J Yu, E S Lo, E J Cochran, et al.
Experimental Neurology
|
October 1, 1991
Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures
P M Carvey, L R Ptak, E S Lo, et al.
Neurology
|
October 1, 1996
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels
E J Pappert, C C Tangney, C G Goetz, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 65) with videos related to
Sort By:
Page
of 7
Pharmacology, Biochemistry, and Behavior
|
February 1, 1990
Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity
P M Carvey, L C Kao, T J Zhang, et al.
Neuroscience Letters
|
November 22, 1988
An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation
A McRae-Degueurce, H L Klawans, R D Penn, et al.
Experimental Neurology
|
March 1, 1993
Striatal extracts from patients with Parkinson's disease promote dopamine neuron growth in mesencephalic cultures
P M Carvey, L R Ptak, S T Nath, et al.
Neurology
|
March 4, 1998
Intravenous levodopa in hallucinating Parkinson's disease patients: high-dose challenge does not precipitate hallucinations
C G Goetz, E J Pappert, L M Blasucci, et al.
Brain Research
|
March 10, 2000
Striatal trophic activity is reduced in the aged rat brain
Z D Ling, T J Collier, C E Sortwell, et al.
Neurotoxicology and Teratology
|
March 1, 1994
Hypoxia after prenatal cocaine attenuates striatal dopamine and neurotrophic activity
D E Weese-Mayer, J M Silvestri, D Lin, et al.
Brain Research. Developmental Brain Research
|
December 28, 1999
Prenatal cocaine exposure reduces glial cell line-derived neurotrophic factor (GDNF) in the striatum and the carotid body of the rat: implications for DA neurodevelopment
J W Lipton, Z Ling, T Q Vu, et al.
Experimental Neurology
|
March 1, 1994
Cerebrospinal fluid from patients with Parkinson's disease alters the survival of dopamine neurons in mesencephalic culture
S J Yu, E S Lo, E J Cochran, et al.
Experimental Neurology
|
October 1, 1991
Levodopa reduces the growth promoting effects of striatal extracts on rostral mesencephalic tegmentum cultures
P M Carvey, L R Ptak, E S Lo, et al.
Neurology
|
October 1, 1996
Alpha-tocopherol in the ventricular cerebrospinal fluid of Parkinson's disease patients: dose-response study and correlations with plasma levels
E J Pappert, C C Tangney, C G Goetz, et al.
Page
of 7